
89bio, Inc. — Investor Relations & Filings
89bio, Inc. is a clinical-stage biopharmaceutical company that develops therapies for liver and cardiometabolic diseases. The company's lead product candidate, pegozafermin, is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). The company focuses on creating innovative and potentially best-in-class treatments to address unmet medical needs in its target patient populations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| Regulatory Filings 2025 | 2025-11-20 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-13 | English | |
| 15-12G | 2025-11-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 31702524 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
|
2025
14 filings
| |||||
| 13197454 | Regulatory Filings 2025 | 2025-11-20 | English | ||
| 13197455 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13197456 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13197457 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13197458 | 15-12G | 2025-11-10 | English | ||
| 13197459 | Major Shareholding Notification 2025 | 2025-11-03 | English | ||
| 13197460 | Director's Dealing 2025 | 2025-11-03 | English | ||
| 13197461 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 13197462 | 4 | 2025-10-30 | English | ||
| 13197463 | 4 | 2025-10-30 | English | ||
| 13197464 | 4 | 2025-10-30 | English | ||
| 13197465 | 4 | 2025-10-30 | English | ||
| 13197466 | 4 | 2025-10-30 | English | ||
| 13197467 | 4 | 2025-10-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
|
AFC-HD AMS Life Science Co.,Ltd.
An OEM of health foods, supplements, and cosmetics with int…
|
2927 | JP | Manufacturing |
|
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived O…
|
FXA | CA | Manufacturing |
89bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31613/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31613 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31613 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31613 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31613}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 89bio, Inc. (id: 31613)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.